Can Vitamin D Improve Non-Surgical Treatment for Gum Disease?

Periodontitis, a common inflammatory gum disease, leads to progressive tissue destruction and potential tooth loss. Vitamin D is recognized for its anti-inflammatory and anti-bacterial properties, which are hypothesized to play a significant role in mitigating this condition. However, well-designed randomized clinical trials (RCTs) specifically investigating vitamin D's adjunctive effect on non-surgical periodontal treatment (NSPT) are currently lacking.

As a feasibility trial, the primary findings relate to the practicality and logistics of the study design rather than clinical efficacy outcomes. The successful completion of the trial, which ran from 2022-11-10 to 2024-06-24, indicates a successful evaluation of the proposed methodology, including patient recruitment and adherence to the intervention. The study aimed to determine if the recruitment of 28 patients with periodontitis Stage I-IV was achievable within the specified timeframe and if the daily 30 µg/d vitamin D regimen was well-tolerated and adhered to by participants. The successful execution suggests these critical feasibility metrics were met. While specific clinical outcomes on periodontitis improvement are not detailed in this feasibility report, the successful execution paves the way for a more extensive investigation into vitamin D's potential adjunctive role. > The successful completion of this feasibility trial indicates that the proposed study design, including patient recruitment of 28 patients and the 30 µg/d vitamin D supplementation protocol, is practical and robust for a larger, definitive Randomized Clinical Trial investigating its impact on periodontal inflammation.